Factors associated with nonadherence to antiretroviral therapy in HIV-positive smokers

AIDS Patient Care and STDs

Volumn 26, Issue 8, 2012, Pages 479-485

  Marks King, Rachel ^a   Vidrine, Damon J ^a   Danysh, Heather E ^a   Fletcher, Faith E ^a   McCurdy, Sheryl ^b   Arduino, Roberto C ^c   Gritz, Ellen R ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; ILLICIT DRUG;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AIDS PATIENT; ALCOHOL CONSUMPTION; ARTICLE; CIGARETTE SMOKING; CONFIDENCE INTERVAL; CONTROLLED STUDY; DEMOGRAPHY; DEPRESSION; DRUG USE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; SMOKING CESSATION; STRESS; TOBACCO DEPENDENCE;

ADULT; ALCOHOL DRINKING; ANTI-HIV AGENTS; ATTITUDE TO HEALTH; DEPRESSION; FEMALE; HIV SEROPOSITIVITY; HUMANS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; QUESTIONNAIRES; RISK FACTORS; SMOKING; SOCIAL SUPPORT; STRESS, PSYCHOLOGICAL; UNITED STATES;

EID: 84864692272     PISSN: 10872914     EISSN: 15577449     Source Type: Journal    
DOI: 10.1089/apc.2012.0070     Document Type: Article

References (46)

1. Feldman JG, Minkoff H, Schneider MF, et al. Association of cigarette smoking with HIV prognosis among women in the HAART era: A report from the women's interagency HIV study. Am J Public Health 2006;96:1060-1065.
2. Gross R, Yip B, Lo Re V, 3rd, et al. A simple, dynamic measure of antiretroviral therapy adherence predicts failure to maintain HIV-1 suppression. J Infect Dis 2006;194:1108-1114.
3. Shuter J. Forgiveness of non-adherence to HIV-1 antiretroviral therapy. J Antimicrob Chemother 2008;61:769-773.
4. Shuter J, Bernstein SL. Cigarette smoking is an independent predictor of nonadherence in HIV-infected individuals receiving highly active antiretroviral therapy. Nicotine Tob Res 2008;10:731-736.
5. Webb MS, Vanable PA, Carey MP, Blair DC. Medication adherence in HIV-infected smokers: The mediating role of depressive symptoms. AIDS Educ Prev 2009;21(3 Suppl):94-105.
6. Drach L, Holbert T, Maher J, Fox V, Schubert S, Saddler LC. Integrating smoking cessation into HIV care. AIDS Patient Care STDs 2010;24:139-140.
7. Webb MS, Vanable PA, Carey MP, Blair DC. Cigarette smoking among HIV + men and women: Examining health, substance use, and psychosocial correlates across the smoking spectrum. J Behav Med 2007;30:371-383.
8. Burkhalter JE, Springer CM, Chhabra R, Ostroff JS, Rapkin BD. Tobacco use and readiness to quit smoking in lowincome HIV-infected persons. Nicotine Tob Res 2005;7:511-522.
9. Gritz ER, Vidrine DJ, Lazev AB, Amick BC, 3rd, Arduino RC. Smoking behavior in a low-income multiethnic HIV/AIDS population. Nicotine Tob Res 2004;6:71-77.
10. Mamary EM, Bahrs D, Martinez S. Cigarette smoking and the desire to quit among individuals living with HIV. AIDS Patient Care STDs 2002;16:39-42.
11. Crothers K, Goulet JL, Rodriguez-Barradas MC, et al. Impact of cigarettes smoking on mortality in HIV-positive and HIVnegative veterans. AIDS Educ Prev 2009;21(Supp A):40.
12. Cockerham L, Scherzer R, Zolopa A, et al. Association of HIV infection, demographic and cardiovascular risk factors with all-cause mortality in the recent HAART era. J Acquir Immune Defic Syndr 2010;53:102-106.
13. Lifson AR, Neuhaus MS, Arribas JR, et al. Smoking-related health risks among persons with HIV in the Strategies for Management of Antiretroviral Therapy Clinical Trial. Am J Public Health 2010;100:1896-1930.
14. Cohall AT, Senathirajah Y, Dini S, Nye A, Powell D, Powell B. An online audio computer-assisted self-interview for prescreening prior to rapid HIV testing in a vulnerable population. AMIA Annu Symp Proc 2007:915.
15. Pluhar E, McDonnell Holstad M, Yeager KA, et al. Implementation of audio computer-assisted interviewing software in HIV/AIDS research. J Assoc Nurses AIDS Care 2007;18:51-63.
16. Vidrine DJ, Marks RM, Arduino RC, Gritz ER. Efficacy of cell phone-delivered smoking cessation counseling for persons living with HIV/AIDS: 3-month outcomes. Nicotine Tob Res 2012;14:106-110.
17. Radloff LS. The CES-D scale: A self-report depression scale for research in the general population. Appl Psychol Meas 1977;1:385-401.
18. Penzak SR, Reddy YS, Grimsley SR. Depression in patients with HIV infection. Am J Health Syst Pharm 2000;57:376-386; quiz 387-389.
19. Velicer WF, Diclemente CC, Rossi JS, Prochaska JO. Relapse situations and self-efficacy: An integrative model. Addict Behav 1990;15:271-283.
20. Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. J Health Soc Behav 1983;24:385-396.
21. Gritz ER, Carr CR, Rapkin D, et al. Predictors of long-term smoking cessation in head and neck cancer patients. Cancer Epidemiol Biomarkers Prev 1993;2:261-270.
22. Cinciripini PM. Development and validation of a coping skills scale for smoking cessation. Society for Research on Nicotine and Tobacco Annual Meeting. Washington, D.C.,1996.
23. Cinciripini PM, Lapitsky L, Seay S, Wallfisch A, Meyer WJ, Van Vunakis H. A placebo-controlled evaluation of the effects of buspirone on smoking cessation: Differences between highand low-anxiety smokers. J Clin Psychopharmacol 1995;15: 182-191.
24. Heatherton TF, Kozlowski LT, Frecker RC, Fagerstrom KO. The Fagerstrom Test for Nicotine Dependence: A revision of the Fagerstrom Tolerance Questionnaire. Br J Addict 1991;86:1119-1127.
25. Saunders JB, Aasland OG, Babor TF, De La Fuente JR, Grant M. Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption-II. Addiction 1993;88:791-804.
26. Boarts JM, Bogart LM, Tabak MA, Armelie AP, Delahanty DL. Relationship of race-, sexual orientation-, and HIVrelated discrimination with adherence to HIV treatment: A pilot study. J Behav Med 2008;31:445-451.
27. Simoni JM, Frick PA, Huang B. A longitudinal evaluation of a social support model of medication adherence among HIV-positive men and women on antiretroviral therapy. Health Psychol 2006;25:74-81.
28. Schackman BR, Ribaudo HJ, Krambrink A, Hughes V, Kuritzkes DR, Gulick RM. Racial differences in virologic failure associated with adherence and quality of life on efavirenzcontaining regimens for initial therapy results of ACTG A5095. J Acquir Immune Defic Syndr 2007;46:547-554.
29. Gonzalez JS, Penedo FJ, Antoni MH, et al. Social support, positive states of mind, and HIV treatment adherence in men and women living with HIV/AIDS. Health Psychol 2004;23:413-418.
30. Chesney MA, Ickovics JR, Chambers DB, et al. Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: The ACCTG Adherence Instruments. AIDS Care 2000;12:255-266.
31. Zhou X, Nonnemaker J, Sherrill B, Gilsenan AW, Coste F, West R. Attempts to quit smoking and relapse: Factors associated with success or failure from the ATTEMPT cohort study. Addict Behav 2009;34:365-373.
32. Lloyd-Richardson EE, Stanton CA, Papandonatos GD, et al. Motivation and patch treatment for HIV + smokers: A randomized controlled trial. Addiction 2009;104:1891-1900.
33. Fiore MC, Jaén CR, Baker TB, et al. Treating Tobacco Use and Dependence: 2008 Update. Clinical Practice Guideline. Rockville, MD: U.S. Department of Health and Human Services. Public Health Service. May 2008.
34. Ammassari A, Trotta MP, Murri R, et al. Correlates and predictors of adherence to highly active antiretroviral therapy: Overview of published literature. J Acquir Immune Defic Syndr 2002;31(Suppl 3):S123-S127.
35. Chander G, Lau B, Moore RD. Hazardous alcohol use: A risk factor for non-adherence and lack of suppression in HIV infection. J Acquir Immune Defic Syndr 2006;43:411-417.
36. De Jong BC, Prentiss D, McFarland W, Machekano R, Israelski DM. Marijuana use and its association with adherence to antiretroviral therapy among HIV-infected persons with moderate to severe nausea. J Acquir Immune Defic Syndr 2005;38:43-46.
37. Knowlton AR, Arnsten JH, Eldred LJ, et al. Antiretroviral Use among active injection-drug users: The role of patient-provider engagement and structural factors. AIDS Patient Care STDs 2010;24:421-428.
38. Holmes WC, Bilker WB, Wang H, Chapman J, Gross R. HIV/AIDS-specific quality of life and adherence to antiretroviral therapy over time. J Acquir Immune Defic Syndr 2007;46:323-327.
39. Stone VE. Strategies for optimizing adherence to highly active antiretroviral therapy: Lessons from research and clinical practice. Clin Infect Dis 2001;33:865-872.
40. Vidrine DJ, Arduino RC, Gritz ER. The Effects of smoking abstinence on symptom burden and quality of life among persons living with HIV/AIDS. AIDS Patient Care STDs 2007;21:659-666.
41. Valdiserri RO. Mapping the roots of HIV/AIDS complacency: Implication for program and policy development. AIDS Educ Prev 2004;16:426-439.
42. Kendzor DE, Costello TJ, Li Y, et al. Race/ethnicity and multiple cancer risk factors among individuals seeking smoking cessation treatment. Cancer Epidemiol Biomarkers Prev 2008;17:2937-2945.
43. Blankenship K, Friedman S, Dworkin S, Mantell J. Structural interventions: Concepts, challenges and opportunities for research. J Urban Health 2006;83:59-72.
44. Link BG, Phelan J. Social conditions as fundamental causes of disease. J Health Soc Behav 1995;14:80-94.
45. Cui Q, Robinson L, Elston D, et al. Safety and tolerability of varenicline tartrate (Champix-/Chantix-) for smoking cessation in HIV-infected subjects: A pilot open-label study. AIDS Patient Care STDs 2012;26:12-19.
46. Halpern MT. Effect of smoking characteristics on cognitive dissonance in current and former smokers. Addict Behav 1994;19:209-217.